Publications en collaboration avec des chercheurs de Instituto de Investigación Sanitaria Gregorio Marañón (22)

2024

  1. Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy

    Blood transfusion = Trasfusione del sangue, Vol. 22, Núm. 3, pp. 239-245

  2. Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients

    Transplantation and Cellular Therapy, Vol. 30, Núm. 3, pp. 306.e1-306.e12

2023

  1. Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide

    Annals of Hematology, Vol. 102, Núm. 6, pp. 1561-1567

  2. Red Blood Cell Transfusion after Postpartum Hemorrhage: Clinical Variables Associated with Lack of Postpartum Hemorrhage Etiology Identification

    Journal of Clinical Medicine, Vol. 12, Núm. 19

  3. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy

    Frontiers in immunology, Vol. 14, pp. 1165759

2022

  1. Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy

    Transfusion, Vol. 62, Núm. 10, pp. 2143-2147

  2. Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation

    Frontiers in immunology, Vol. 13, pp. 1002959

  3. Clinical grade production of IL-15 stimulated NK cells for early infusion in adult AML patients undergoing haploidentical stem cell transplantation with post-transplant cyclophosphamide

    Transfusion, Vol. 62, Núm. 2, pp. 374-385

  4. FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia

    Cancers, Vol. 14, Núm. 16

  5. Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

    International Journal of Hematology, Vol. 115, Núm. 1, pp. 61-68

2021

  1. Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre

    Blood transfusion = Trasfusione del sangue, Vol. 19, Núm. 4, pp. 292-299

2020

  1. Immunotherapy with CAR-T cells in paediatric haematology-oncology

    Anales de Pediatria, Vol. 93, Núm. 1, pp. 59.e1-59.e10

2019

  1. Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia

    International Journal of Clinical Pharmacy, Vol. 41, Núm. 5, pp. 1143-1147

  2. Mononuclear cell collection for extracorporeal photopheresis by using the “off-line” system: A comparative study between COBE Spectra and Spectra Optia devices

    Journal of Clinical Apheresis, Vol. 34, Núm. 4, pp. 359-366

  3. Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation

    Blood Advances, Vol. 3, Núm. 21, pp. 3351-3359

  4. Successful Treatment of Severe Aspergillosis with Isavuconazole Therapy after Allogeneic Stem Cell Transplantation

    Chemotherapy, Vol. 64, Núm. 2, pp. 57-61

2017

  1. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML

    Bone Marrow Transplantation, Vol. 52, Núm. 8, pp. 1138-1143

  2. Transient hemolysis due to anti-D and anti-A1 produced by engrafted donor's lymphocytes after allogeneic unmanipulated haploidentical hematopoietic stem cell transplantation

    Transfusion, Vol. 57, Núm. 10, pp. 2355-2358

2016

  1. Inhibitory killer cell immunoglobulin-like receptor (iKIR) mismatches improve survival after T-cell-repleted haploidentical transplantation

    European Journal of Haematology, Vol. 96, Núm. 5, pp. 483-491

  2. Transfusion service management of sickle-cell disease patients

    Vox Sanguinis, Vol. 110, Núm. 3, pp. 288-294